# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 71-80 of 4051 results.
Seroprevalence of Hepatitis E in People With an Organ Transplant
Status: Completed
Last Changed: Mar 26, 2020
First Received: Jul 15, 2014
Disease(s): Hepatitis E
Locations: Georgetown University, Washington, District of Columbia, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Wisconsin, Madison, Wisconsin, United States
Community Access, Retention in Care, and Engagement for Hepatitis C Treatment
Status: Active, not recruiting
Last Changed: Jan 07, 2020
First Received: Jul 10, 2018
Disease(s): Hepatitis C
Intervention(s): PREP-C, Modified ECHO
Locations: University of Kentucky, Lexington, Kentucky, United States
A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
Status: Completed
Last Changed: Sep 01, 2016
First Received: Nov 11, 2015
Disease(s): Hepatitis E
Intervention(s): 30μg/0.5ml Hepatitis E vaccine, 30μg/0.5ml Recombinant Hepatitis E vaccine
Locations: Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
Hepatitis B Vaccine for Non-responders
Status: Completed
Last Changed: Jan 31, 2019
First Received: Jan 30, 2018
Disease(s): Hepatitis B
Intervention(s): HBVaxPro, HBAI20
Locations: Vaxinfectio - Antwerp University, Antwerp, Belgium
Ziekenhuis Oost-Limburg, Genk, Belgium
Maastricht UMC, Maastricht, Netherlands
Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Status: Terminated
Last Changed: Jun 15, 2016
First Received: May 04, 2012
Disease(s): Hepatitis C
Intervention(s): Peginterferon alfa-2a, Ribavirin, telaprevir
Locations: University of Chicago Medical Center, Chicago, Illinois, United States
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
Status: Completed
Last Changed: Dec 17, 2013
First Received: May 09, 2011
Disease(s): Hepatitis A
Intervention(s): HAVpur Junior, Havrix 720 Junior
Locations: Medical College and Chacha Nehru Bal Chikitsalay, Indore, Madhya Pradesh, India
Rajiv Ghandi Medical College, Thane, Maharashtra, India
Christian Medical College and Hospital, Ludhiana, Punjab, India
Autoimmune Hepatitis Study
Status: Terminated
Last Changed: Jul 09, 2008
First Received: Feb 03, 2006
Disease(s): Hepatitis, Autoimmune
Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays
Status: Not yet recruiting
Last Changed: Feb 28, 2020
First Received: Feb 28, 2020
Disease(s): Hepatitis B
Intervention(s): Xpert® HBV DNA fingerstick point of care assay, Point of Care ALT, Xpert® HBV DNA point of care assay from dried blood spot
Locations: St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients
Status: Unknown status
Last Changed: May 31, 2017
First Received: Mar 23, 2015
Disease(s): Hepatitis C
Locations: Dr. Rudolf Dinkelacker, Crailsheim, Baden Württemberg, Germany
Dr. Manfred Hartmann, Herrenberg, Baden-Württenberg, Germany
Dr. Reinhold Burr, Hirrlingen, Baden-Württenberg, Germany
Dr. Christoph von Ascheraden, St. Blasien, Baden-Württenberg, Germany
Dr. Barbara Haider, Aichach, Bayern, Germany
... and 28 other locations.
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
Status: Recruiting
Last Changed: Oct 28, 2020
First Received: Feb 01, 2019
Disease(s): Hepatitis B
Intervention(s): Peripheral iv
Locations: Xiangya Hospital Central South University, Changsha, Hunan, China